| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |